CXCR4+ and SDF-1+ Bone Marrow Cells Are Mobilized into the Blood Stream in Acute Myocardial Infarction and Acute Ischemia
Read full paper at:
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=47093#.VGGcGWfHRK0
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=47093#.VGGcGWfHRK0
Author(s)
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Laboratorio de Hormonas, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Inmunobiología Biología Celular y Tisular, Facultad de Medicina UNAM, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Inmunobiología Biología Celular y Tisular, Facultad de Medicina UNAM, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Laboratorio de Hormonas, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
División de Cardiocirugía, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Inmunobiología Biología Celular y Tisular, Facultad de Medicina UNAM, México DF, México.
Departamento de Hematología, Centro Médico Nacional 20 de Noviembre ISSSTE, México DF, México.
Departamento de Inmunobiología Biología Celular y Tisular, Facultad de Medicina UNAM, México DF, México.
Cell therapy has shown beneficial effects on
ventricular function and tissue regeneration in patients with acute and
chronic myocardial infarction, although with diverse grades of
variability in the results, possibly by proportion, subtype and cell
cycle status. Objective: Identify and phenotypically characterize, via
CXCR4 and SDF-1 expression, the bone marrow cell subpopulations that are
mobilized into the bloodstream in patients with Acute Myocardial
Infarction (AMI) and Acute Ischemia (AI) such as acute angina and
Chronic Ischemia (CI) such as chronic stable angina, and also determine
the cell cycle status of these cells. Method: Patients with AMI and AI
were recruited in the ICCU, and patients with CI in the departments of
cardiology and cardiovascular surgery. The quantification of cellular
subpopulations was made by cytofluorometry with a FACS caliburcyto
fluorometry (Becton Dickinson) with specific FITC-labeled anti human
monoclonal antibodies against CD34, CD133, CD117, CD48, CXCR4, SDF-1 and
Ki67 (Becton Dickinson). Serum concentration of IL-6 and IL-8 were
determined by a sequential solid phase chemiluminescent assay performed
in a SIEMENS IMMULITE 1000 Analyzer. Statistical analysis was made with
the SPSS version 20.0 for Windows. A p value < 0.05 was
considered as statistical significant. Results: We analyzed 174
patients. 67 had Acute Myocardial Infarction, 55 Acute Ischemia and 52
Chronic Ischemia. Total cellularity of bone marrow and SDF-1+ cells was
significantly higher in patients with AMI (14.6 ± 1.5 × 103/ml) than that in AI (9.2 ± 1.3 × 103/ml) and CI (6.6 ± 1.1 × 103/ml) patients (p
< 0.001). There were no significant differences in the amount of
CD34+, CD117+, CD133+ and CD48+ cells between AMI (49.9 ± 3.9, 45 ± 4.7,
43.2 ± 3.7, 35.4 ± 6.7 respectively) and AI (36.7 ± 2.5, 36 ± 3.2, 33.7
± 5.1, 32 ± 5 respectively) patients (p = 0.22 to 0.39), but
interestingly in AMI and AI patients, cells were CXCR4+ in almost half
of these mobilized cells, although the proportion was significantly
higher in AMI patients (46.8% ± 7.1% to 55.7% ± 6.3% vs 23% ± 1.6% to
28.4% ± 2.1%, p = 0.03 to 0.05). A similar behavior was observed
with the Ki67 antibody (29.9% ± 2.1% to 36.1% ± 6.3% vs 10% ± 1.2% to
24% ± 1.1%, p = 0.001 to 0.05). Bivariate analysis of the results
showed a significant correlation of the cell proportion in AMI but not
in AI and CI patients (p = 0.001 to 0.05; 0.12 to 0.87 and 0.17
to 0.92 respectively). The amount of myocardial tissue infarcted did not
show any correlation with the amount of cellular subpopulations
mobilized to peripheral blood (r = 0.10 to 0.20; p = 0.21
to 0.64) from the bone marrow. Conclusion: The proportion of cellular
subpopulations with regenerative potential mobilized to circulation
during an event of Acute Myocardial Infarction is significantly higher
than during an event of acute angina and chronic stable angina, with a
significant proportion of mobilized cells that expressed CXCR4, most of
which were already in some of the cell cycle phases.
Cite this paper
Aceves, J. , Vilchis, R. , Medina, M. , Borja, M. ,
Cortes, S. , Díaz, G. , Castro, A. , Gómez, A. , Parra, J. , Alvarado,
M. , Hernández, M. , Poveda, V. , Masso, F. and Montaño, L. (2014)
CXCR4+ and SDF-1+ Bone Marrow Cells Are Mobilized into the Blood Stream
in Acute Myocardial Infarction and Acute Ischemia. World Journal of Cardiovascular Diseases, 4, 361-367. doi: 10.4236/wjcd.2014.47045.
| [1] |
Kajstura, J., Leri, A.,
Castaldo, C., Nadal-Ginard, B. and Anversa, P. (2004) Myocyte Growth in
the Failing Heart. Surgical Clinics of North America, 84, 161-177. http://dx.doi.org/10.1016/S0039-6109(03)00215-9 |
| [2] |
Timmermans, F., De Sutter, J.
and Gillebert, T.C. (2003) Stem Cells for the Heart, Are We There Yet?
Cardiology, 100, 176-185. http://dx.doi.org/10.1159/000074811 |
| [3] |
Urbanek, K., Quaini, F., Tasca,
G., Torella, D., Castaldo, C., Nadal-Ginard, B., Leri, A., Kajstura, J.,
Quaini, E. and Anversa, P. (2003) Intense Myocyte Formation from
Cardiac Stem Cells in Human Cardiac Hypertrophy. Proceedings of the
National Academy of Sciences of the United States of America, 100,
10440-10445. http://dx.doi.org/10.1073/pnas.1832855100 |
| [4] |
Assmus, B., Schachinger, V.,
Teupe, C., Britten, M., Lehmann, R., Dobert, N., Grunwald, F., Aicher,
A., Urbich, C., Martin, H., Hoelzer, D., Dimmeler, S. and Zeiher, A.M.
(2002) Transplantation of Progenitor Cells and Regeneration Enhancement
in Acute Myocardial Infarction (TOPCARE-AMI). Circulation, 106,
3009-3017. http://dx.doi.org/10.1161/01.CIR.0000043246.74879.CD |
| [5] |
Vulliet, P.R., Greeley, M.,
Halloran, S.M., Mac-Donald, K.A. and Kittleson, M.D. (2004)
Intra-Coronary Arterial Injection of Mesenchymal Stromal Cells and
Microinfarction in Dogs. Lancet, 363, 783-784. http://dx.doi.org/10.1016/S0140-6736(04)15695-X |
| [6] |
Zhang, G., Nakamura, Y., Wang,
X., Hu, Q., Suggs, L.J. and Zhang, J. (2007) Controlled Release of
Stromal Cell-Derived Factor-1 Alpha in Situ Increases c-Kit Cell Homing
to the Infarcted Heart. Tissue Engineering, 13, 2063-2071. http://dx.doi.org/10.1089/ten.2006.0013 |
| [7] |
Tang, Y.L., Zhu, W., Cheng, M.,
Chen, L., Zhang, J., Sun, T., et al. (2009) Hypoxic Preconditioning
Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of
Myocardial Infarction by Inducing CXCR4 Expression. Circulation
Research, 104, 1209-1216. http://dx.doi.org/10.1161/CIRCRESAHA.109.197723 |
| [8] |
Janewit, D., Altuntas, C.Z.,
Johnson, J.M., Yong, S., Wickley, P.J. and Clark, P. (2007) Beta
1-Adrenergic Receptor Autoantibodies Mediate Dilated Cardiomyopathy by
Agonistically Inducing Cardiomyocyte Apoptosis. Circulation, 116,
399-410. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.683193 |
| [9] |
Assmus, B., Fischer-Rasokat, U.,
Honold, J., Seeger, F.H., Fichtlscherer, S. and Tonn, T. (2007)
Transcoronary Transplantation of Functionally Competent BMCs Is
Associated with a Decrease in Natriuretic Peptide Serum Levels and
Improved Survival of Patients with Chronic Postinfarction Heart Failure:
Results of the TOPCARE-CHD Registry. Circulation Research, 100,
1234-1241. http://dx.doi.org/10.1161/01.RES.0000264508.47717.6b |
| [10] |
Penn, M.S. (2009) Importance of
the SDF-1:CXCR4 Axis in Myocardial Repair. Circulation Research, 104,
1133-1135. http://dx.doi.org/10.1161/CIRCRESAHA.109.198929 |
| [11] |
Lévesque, J.P., Hendy, J.,
Winkler, I.G., Takamatsu, Y. and Simmons, P.J. (2003) Granulocyte
Colony-Stimulating Factor Induces the Release in the Bone Marrow of
Pro-Teases That Cleave c-KIT Receptor (CD117) from the Surface of
Hematopoietic Progenitor Cells. Experimental Hematology, 31, 109-117. http://dx.doi.org/10.1016/S0301-472X(02)01028-7 |
| [12] |
Brunskill, S.J., Hyde, C.J.,
Doree, C.J., Watt, S.M. and Martin-Rendon, E. (2009) Route of Delivery
and Baseline Left Ventricular Ejection Fraction, Key Factors of
Bone-Marrow-Derived Cell Therapy for Ischaemic Heart Disease. European
Journal of Heart Failure, 11, 887-896. http://dx.doi.org/10.1093/eurjhf/hfp101 |
| [13] |
Yeh, E.T., Zhang, S., Wu, H.D.,
Korbling, M., Willerson, J.T. and Estrov, Z. (2003) Transdifferentiation
of Human Peripheral Blood CD34-Enriched Cell Population into
Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells in Vivo.
Circulation, 108, 2070-2073. http://dx.doi.org/10.1161/01.CIR.0000099501.52718.70 |
| [14] | Suarez de Lezo, J., Herrera, C., Pan, M., Romero, M., Pavlovic, D., Segura, J., Sanchez, J., Ojeda, S. and Torres, A. (2007) Regenerative Therapy in Patients with a Revascularized Acute Anterior Myocardial Infarction and Depressed Ventricular Function. Revista Española de Cardiología, 60, 357-365. |
| [15] |
Archundia, A., Aceves, J.L.,
Lopez-Hernandez, M., Alvarado, M., Rodriguez, E., Diaz Quiroz, G., Paez,
A., Rojas, F.M. and Montaño, L.F. (2005) Direct Cardiac Injection of
G-CSF Mobilized Bone-Marrow Stem-Cells Improves Ventricular Function in
Old Myocardial Infarction. Life Sciences, 78, 279-283. http://dx.doi.org/10.1016/j.lfs.2005.04.080 |
| [16] |
Aceves, J.L., Archundia, A.,
Paez, A., Vilchis, R., Varela, E. and Rodriguez, E. (2012) Efficacy and
Long-Term Evaluation of Intramyocardial Injection of Autologous
CD34-Enriched PBMSC in Old Myocardial Infarction. World Journal of
Cardiovascular Diseases, 2, 283-290. http://dx.doi.org/10.4236/wjcd.2012.24044 |
| [17] |
Bartunek, J., Dimmeler, S.,
Drexler, H., Fernandez-Aviles, F., Galinanes, M. and Janssens, S. (2006)
Task Force of the European Society of Cardiology. The Consensus of the
Task Force of the European Society of Cardiology Concerning the Clinical
Investigation of the Use of Autologous Adult Stem Cells for Repair of
the Heart. European Heart Journal, 27, 1338-1340. http://dx.doi.org/10.1093/eurheartj/ehi793 |
| [18] |
Strauer, B.E., Brehm, M., Zeus,
T., Kostering, M., Hernandez, A., Sorg, R.V., et al. (2002) Repair of
Infarcted Myocardium by Autologous Intra-Coronary Mononuclear Bone
Marrow Cell Transplantation in Humans. Circulation, 106, 1913-1918. http://dx.doi.org/10.1161/01.CIR.0000034046.87607.1C |
| [19] |
Mathur, A. and Martin, J.F.
(2004) Stem Cells and Repair of the Heart. Lancet, 364, 183-192. http://dx.doi.org/10.1016/S0140-6736(04)16632-4 |
| [20] |
Tse, H.F., Kwong, Y.L., Chan,
J.K., Lo, G., Ho, C.L. and Lau, C.P. (2003) Angiogenesis in Ischaemic
Myocardium by Intra-myocardial Autologous Bone Marrow Mononuclear Cell
Implantation. Lancet, 361, 47-49. http://dx.doi.org/10.1016/S0140-6736(03)12111-3 |
| [21] |
Askari, A., Unzek, S., Popovic,
Z.B., Goldman, C.K., Forudi, F., kiedrowski, M., Rovner, A., Ellis,
S.G., Thomas, J.D., DiCorleto, P.E., Topol, E.J. and Penn, M.S. (2003)
Effect of Stromal-Cell-Derived Factor-1 on Stem Cell Homing and Tissue
Regeneration in Ischemic Cardiomyopathy. Lancet, 362, 697-703. http://dx.doi.org/10.1016/S0140-6736(03)14232-8 |
| [22] |
Schachinger, V., Erbs, S.,
Elsasser, A., Haberbosch, W., Hambrecht, R., Holschermann, H., Yu, J.,
Corti, R., Mathey, D.G., Hamm, C.W., Suselbeck, T., Assmus, B., Tonn,
T., Dimmeler, S. and Zeiher, A.M. (2006) Intracoronary Bone Marrow
Derived Progenitor Cells in Acute Myocardial Infarction. The New England
Journal of Medicine, 355, 1210-1221. http://dx.doi.org/10.1056/NEJMoa060186 |
| [23] |
Hu, X., Dai, S., Wu, W.J., Tan,
W., Zhu, X., Mu, J., Guo, Y., Bolli, R. and Rokosh, G. (2007) Stromal
Cell Derived Factor-1 Alpha Confers Protection against Myocardial
Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell Derived
Factor-1 Alpha CXCR4 Axis. Circulation, 116, 654-663. http://dx.doi.org/10.1161/CIRCULATIONAHA.106.672451 |
| [24] |
Zagzag, D., Lukyanov, Y., Lan,
L., Ali, M.A., Esencay, M., Mendez, O., Yee, H., Voura, E.B. and
Newcomb, E.W. (2006) Hypoxia-Inducible Factor 1 and VEGF Upregulate
CXCR4 in Glioblastoma: Implications for Angiogenesis and Glioma Cell
Invasion. Laboratory Investigation, 86, 1221-1232. http://dx.doi.org/10.1038/labinvest.3700482 |
| [25] |
Phillips, R.J., Mestas, J.,
Gharaee-Kermani, M., Burdick, M.D., Sica, A., Belperio, J.A., Keane,
M.P. and Strieter, R.M. (2005) Epidermal Growth Factor and
Hypoxia-Induced Expression of CXC Chemokine Receptor 4 on Non-Small Cell
Lung Cancer Cells Is Regulated by the Phosphatidylinositol
3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and
Activation of Hypoxia Inducible Factor-1 Alpha. The Journal of
Biological Chemistry, 280, 22473-22481. http://dx.doi.org/10.1074/jbc.M500963200 |
| [26] |
Burchfield, J.S., Iwasaki, M.,
Koyanagi, M., Urbich, C., Rosenthal, N., Zeiher, A.M. and Dimmeler, S.
(2008) Interleukin-10 from Transplanted Bone Marrow Mononuclear Cells
Contributes to Cardiac Protection after Myocardial Infarction.
Circulation Research, 103, 203-211. http://dx.doi.org/10.1161/CIRCRESAHA.108.178475 |
| [27] |
Bock-Marquette, I., Saxena, A.,
White, M.D., Dimaio, J.M. and Srivastava, D. (2004) Thymosin Beta4
Activates Integrin-Linked Kinase and Promotes Cardiac Cell Migration,
Survival and Cardiac Repair. Nature, 432, 466-472. http://dx.doi.org/10.1038/nature03000 eww141111lx |
评论
发表评论